Organon Gets More Skin in the Game by Acquiring Roivant’s Dermatology Subsidiary
Posted
Frank Vinluan (via MedCity News)
By acquiring Dermavant, Organon gets Vtama, a drug approved for treating plaque psoriasis. An FDA decision for the topical cream in atopic dermatitis is expected by the end of 2024.
The post Organon Gets More Skin in the Game by Acquiring Roivant’s Dermatology Subsidiary appeared first on MedCity News.
